ArticleExperimental hematology & oncology2022
Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer.
Fangchao Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it